Chester County News and Community Website
WEST CHESTER, PA — Centinel Spine has secured U.S. Food and Drug Administration approval to use its prodisc C Nova artificial cervical disc at two levels of the spine, expanding …
West Chester Medical Firm Gains Ground With FDA Decision Read More
WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) is approaching a November 10 federal regulatory decision on its preservative-free ketamine product after the Food and Drug Administration requested only minor …
NRx Nears FDA Decision on U.S.-Made Ketamine Product Read More
CLAYMONT, DE — MRI2CT Inc. has received U.S. Food and Drug Administration 510(k) clearance for an artificial intelligence imaging platform that generates three-dimensional bone images of the lower spine from …
MRI2CT Secures FDA Clearance for AI Spine Imaging Platform Read More
MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) has received U.S. Food and Drug Administration clearance for a fully resorbable surgical mesh developed and manufactured at its Malvern facility, expanding …
TELA Bio Wins FDA Clearance for Resorbable Surgical Mesh Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration is seeking public input on safety requirements and clinical trial designs for ibogaine, a psychedelic compound being investigated for opioid use …
FDA Seeks Input on Ibogaine Trials Amid Safety Concerns Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration approved the Autus Size-Adjustable Valve for children with congenital pulmonary valve disease, creating the first U.S. heart valve designed to expand …
FDA Clears Expandable Heart Valve for Children Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration is opening a nationwide recruitment drive for scientific experts and consumer representatives to fill current and anticipated vacancies on advisory committees …
FDA Expands Recruitment for Advisory Committee Vacancies Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Emcitate, or tiratricol, as the first therapy for peripheral thyrotoxicosis in patients with MCT8 deficiency, establishing a treatment option for …
FDA Clears First Treatment for Rare MCT8 Deficiency Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has proposed a redesigned late-stage development program for its prostate cancer drug Teverelix that could reduce planned enrollment by about 60% while …
ICYMI: Medicus Seeks FDA Path to Cut Teverelix Trial by 60% Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) is preparing for a potential first-half 2027 U.S. launch of its experimental treatment for microcystic lymphatic malformations after completing its FDA application …
Palvella Advances Rare-Disease Drug Toward 2027 Launch Read More